Filing Flows › Outset Medical (OM) › Q3 2026 › vs Q2 2026
Outset Medical (OM) Q3 2026 vs Q2 2026 (quarter over quarter)
Outset Medical's revenue rose $2.0M (+6%) from $31.6M in Q2 2026 to $33.6M in Q3 2026. The biggest changes: Product +$1.8M (+8%); Service and Other Revenue +$175K (+2%).
Outset Medical, Q3 2026: revenue $33.6M (+14% year over year), operating margin -36.5%, net loss $14.7M, operating cash flow −$10.4M. The chart draws each line against Q2 2026, the increases inside each band.
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Consumables Product | $13.2M | $12.4M | $806K | +6% |
| Consoles Product | $10.5M | $9.5M | $980K | +10% |
| Product | $23.7M | $21.9M | $1.8M | +8% |
| Service and Other Revenue | $9.9M | $9.7M | $175K | +2% |
| Revenue | $33.6M | $31.6M | $2.0M | +6% |
| Net loss | $14.7M | $18.0M | −$3.3M | -18% |
| Costs & expenses | $48.3M | $49.6M | −$1.3M | -3% |
| Operating costs | $45.9M | $47.3M | −$1.4M | -3% |
| Interest & other, net | $2.3M | $2.1M | $176K | +8% |
| Income tax | $153K | $220K | −$67K | -30% |
| Cost of revenue | $19.9M | $18.4M | $1.6M | +9% |
| Research & development | $5.9M | $5.5M | $448K | +8% |
| Sales & marketing | $11.7M | $12.2M | −$416K | -3% |
| General & admin | $8.3M | $11.4M | −$3.0M | -27% |
| Operating cash sources | $14.7M | $18.0M | −$3.3M | -18% |
| Depreciation & amortization | $666K | $627K | $39K | +6% |
| Share-based compensation | $1.7M | $2.7M | −$1.0M | -37% |
| Working capital & other | $2.0M | $5.0M | −$3.1M | -61% |
| Cash used in operations | $10.4M | $9.6M | $744K | +8% |
| Net loss absorbed | $14.7M | $18.0M | −$3.3M | -18% |
Questions
How much did Outset Medical's revenue grow quarter over quarter in Q3 2026?
Outset Medical's revenue rose $2.0M (+6%) from $31.6M in Q2 2026 to $33.6M in Q3 2026.
What drove Outset Medical's revenue change in Q3 2026?
Product +$1.8M (+8%); Service and Other Revenue +$175K (+2%).